Abstract
S-11C-methyl-l-cysteine (LMCYS) is an attractive amino acid tracer for clinical tumor positron emission tomography (PET) imaging. d-isomers of some radiolabeled amino acids are potential PET tracers for tumor imaging. In this work, S-11C-methyl-d-cysteine (DMCYS), a d-amino acid isomer of S-11C-methyl-cysteine for tumor imaging was developed and evaluated. DMCYS was prepared by 11C-methylation of the precursor d-cysteine, with an uncorrected radiochemical yield over 50 % from 11CH3I within a total synthesis time from 11CO2 about 12 min. In vitro competitive inhibition studies showed that DMCYS uptake was primarily transported through the Na+-independent system L, and also the Na+-dependent system B0,+ and system ASC, with almost no system A. In vitro incorporation experiments indicated that almost no protein incorporation was found in Hepa 1–6 hepatoma cell lines. Biodistribution studies demonstrated higher uptake of DMCYS in pancreas and liver at 5 min post-injection, relatively lower uptake in brain and muscle, and faster radioactivity clearance from most tissues than those of l-isomer during the entire observation time. In the PET imaging of S180 fibrosarcoma–bearing mice and turpentine-induced inflammatory model mice, 2-18F-fluoro-2-deoxy-d-glucose (FDG) exhibited significantly high accumulation in both tumor and inflammatory lesion with low tumor-to-inflammation ratio of 1.40, and LMCYS showed low tumor-to-inflammation ratio of 1.64 at 60 min post-injection. By contrast, DMCYS showed moderate accumulation in tumor and very low uptake in inflammatory lesion, leading to relatively higher tumor-to-inflammation ratio of 2.25 than 11C-methyl-l-methionine (MET) (1.85) at 60 min post-injection. Also, PET images of orthotopic transplanted glioma models demonstrated that low uptake of DMCYS in normal brain tissue and high uptake in brain glioma tissue were observed. The results suggest that DMCYS is a little better than the corresponding l-isomers as a potential PET tumor-detecting agent and is superior to MET and FDG in the differentiation of tumor from inflammation.
Similar content being viewed by others
References
Bourdier T, Shepherd R, Berghofer P, Jackson T, Fookes CJ, Denoyer D, Dorow DS, Greguric I, Gregoire MC, Hicks RJ, Katsifis A (2011) Radiosynthesis and biological evaluation of l- and d-S-(3-[18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography. J Med Chem 54:860–1870
Deng H, Tang X, Wang H, Tang G, Wen F, Shi X, Yi C, Wu K, Meng Q (2011) S-11C-methyl-l-cysteine: a new amino acid PET tracer for cancer imaging. J Nucl Med 52:287–293
Denoyer D, Kirby L, Waldeck K, Roselt P, Neels OC, Bourdier T, Shepherd R, Katsifis A, Hicks RJ (2012) Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer. Eur J Nucl Med Mol Imaging 39:703–712
Hamacher K, Coenen HH (2002) Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-l-tyrosine. Appl Radiat Isot 57:853–856
Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA (2001) Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432–445
Kubota K (2001) From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15:471–486
Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N (1994) Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 35:104–112
Kumar R, Halanaik D, Malhotra A (2010) Clinical applications of positron emission tomography-computed tomography in oncology. Indian J Cancer 47:100–119
Langen KJ, Muhlensiepen H, Schmieder S, Hamacher K, Broer S, Borner AR, Schneeweiss FH, Coenen HH (2002) Transport of cis- and trans-4-[(18)F]fluoro-l-proline in F98 glioma cells. Nucl Med Biol 29:685–692
Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, Zilles K, Coenen HH (2003) Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 30:501–508
Langstrom B, Antoni G, Gullberg P, Halldin C, Malmborg P, Nagren K, Rimland A, Svard H (1987) Synthesis of l- and d-[methyl-11C]methionine. J Nucl Med 28:1037–1040
Lee TS, Ahn SH, Moon BS, Chun KS, Kang JH, Cheon GJ, Choi CW, Lim SM (2009) Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats. Nucl Med Biol 36:681–686
Maeda Y, Oguni H, Saitou Y, Mutoh A, Imai K, Osawa M, Fukuyama Y, Hori T, Yamane F, Kubo O, Ishii K, Ishiwata K (2003) Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia 44:1118–1121
Nunez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM (2002) Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. J Nucl Med 43:46–55
Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T (2010) Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas. J Neurooncol 99:217–225
Pascali C, Bogni A, Iwata R, Decise D, Crippa F, Bombardieri E (1999) High efficiency preparation of l-[S-methyl-11C]methionine by on-column [11C]methylation on C18 Sep-Pak. J Labelled Compds Radiopharm 42:715–724
Plathow C, Weber WA (2008) Tumor cell metabolism imaging. J Nucl Med 49(Suppl 2):43S–63S
Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Koga H, Hayashi K, Kaneko K, Chen T, Ichiya Y, Masuda K (2001) Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung. Ann Nucl Med 15:425–431
Sloan JL, Mager S (1999) Cloning and functional expression of a human Na+ and Cl− dependent neutral and cationic amino acid transporter B0,+. J Biol Chem 274:23740–23745
Tang GH, Wang MF, Tang XL, Luo L, Gan MQ (2004) Automated synthesis of (S-[11C]-methyl)-l-methionine and (S-[11C]-methyl)-l-cysteine by on-column [11C]methylation. J Nucl Radiochem 26:77–83
Tang GH, Tang XL, Wang MF, Guo XJ (2006) High efficient automated synthesis of 2-[18F]-fluoro-2-deoxy-d-glucose. Nucl Technol 29:531–536
Tsukada H, Sato K, Fukumoto D, Kakiuchi T (2006a) Evaluation of d-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med Mol Imaging 33:1017–1024
Tsukada H, Sato K, Fukumoto D, Nishiyama S, Harada N, Kakiuchi T (2006b) Evaluation of d-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with l- and d-11C-methionine. J Nucl Med 47:679–688
Urakami T, Sakai K, Asai T, Fukumoto D, Tsukada H, Oku N (2009) Evaluation of O-[18F]fluoromethyl-d-tyrosine as a radiotracer for tumor imaging with positron emission tomography. Nucl Med Biol 36:295–303
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N (1995) High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36:1301–1306
Yasukawa T, Yoshikawa K, Aoyagi H, Yamamoto N, Tamura K, Suzuki K, Tsujii H, Murata H, Sasaki Y, Fujisawa T (2000) Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med 41:283–290
Acknowledgments
This work was supported in part by the Science and Technology Foundation of Guangdong Province (No. 2010B031600054), the National High Technology Research and Development Program of China (863 Program, No. 2008AA02Z430), the National Natural Science Foundation of China (No. 81371584), Science and Technology Planning Project of Guangzhou (2011J5200025), and Doctoral Candidate Innovative Personnel Training Project of Sun Yat-Sen University (2012).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, T., Tang, G., Wang, H. et al. Synthesis and preliminary biological evaluation of S-11C-methyl-d-cysteine as a new amino acid PET tracer for cancer imaging. Amino Acids 47, 719–727 (2015). https://doi.org/10.1007/s00726-014-1899-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-014-1899-4